Quantum Capital Management (California)’s United Therapeutics UTHR Stock Holding History

Quantum Capital Management (California)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,245	Closed	-$213K	–	184
2015 Q1	$213K	Sell	1,245 -1,236	-50%	-$188K	0.05%	161
2014 Q4	$321K	Sell	2,481 -405	-14%	-$52.2K	0.07%	144
2014 Q3	$371K	Sell	2,886 -79,454	-96%	-$8.19M	0.07%	139
2014 Q2	$7.29M	Sell	82,340 -10,518	-11%	-$1.01M	1.25%	27
2014 Q1	$8.73M	Sell	92,858 -28,033	-23%	-$2.87M	1.42%	25
2013 Q4	$13.7M	Buy	120,891 +22,626	+23%	+$2.04M	2.32%	2
2013 Q3	$7.75M	Buy	98,265 +5,174	+6%	+$378K	1.53%	19
2013 Q2	$6.13M	Buy	+93,091	New	+$6M	1.25%	34

Other funds holding UTHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Quantum Capital Management (California)'s UTHR Position: Q2 2015 in Review

Quantum Capital Management (California) sold out of United Therapeutics (UTHR) in Q2 2015, closing a stake of 1,245 shares — an estimated $213K sold.

Quantum Capital Management (California) first reported a position in UTHR in Q2 2013 and held it in 8 quarters. The position peaked at $13.7M in Q4 2013. 383 funds tracked by Wall St. Rank hold UTHR as of Q2 2015.

Quantum Capital Management (California) reported no remaining United Therapeutics position as of Q2 2015 after selling out during the quarter.
Quantum Capital Management (California) sold 1,245 United Therapeutics shares in Q2 2015, an estimated $213K.
Quantum Capital Management (California) first reported a position in United Therapeutics in Q2 2013 and held it in 8 quarters.
Quantum Capital Management (California)'s United Therapeutics position peaked at $13.7M in Q4 2013.
383 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2015.

Based on Quantum Capital Management (California)'s 13F filing for Q2 2015, filed 14 Aug 2015.